In a Stage II research, 125 sufferers treated with PROSTVAC achieved an increased 3-year-OS compared to the control group (30% vs. therapy publicity, or with an intrinsic PCa principal aggressiveness.
ROCK inhibitors
In a Stage II research, 125 sufferers treated with PROSTVAC achieved an increased 3-year-OS compared to the control group (30% vs. therapy publicity, or with an intrinsic PCa principal aggressiveness.